Ethics Advisory Committee
The Ethics Advisory Committee (EAC)
The UK Biobank Ethics Advisory Committee (EAC) is a Committee of the UK Biobank Board who’s remit is to provide advice to the Board on ethical issues that arise during the maintenance, development and use of UK Biobank, including:
- Identifying, defining and examining current ethical issues or those on the horizon
- Providing advice, guidance and recommendations on relevant ethical issues
- Reviewing and advising on policies which have an ethical dimension that are relevant to UK Biobank
- Conducting detailed conceptual and empirical ethics research to ensure that advice is evidence-based, and that UK Biobank maintains its robust ethical justification for current and future activity.
Research-led arm of EAC
New researcher joins the Ethics Advisory Committee
As the UK Biobank research resource matures and new technologies provide ever higher resolution, UK Biobank needs to be able to anticipate relevant ethical issues and respond to them in an agile way. To ensure that we are ethically equipped to do this, our new ethics/social science researcher will undertake detailed empirical and conceptual research to support a new research-led arm of the UK Biobank Ethics Advisory Committee. This research will ensure that advice from the committee is evidence-based and responsive to ethical issues as they arise. It will also ensure that UK Biobank will continue to maintain its robust ethical justification for current and future activity. This pioneering approach to integrating social science and ethics research into the very heart of the organisation provides a benchmark for ethics best practice for other similar cohort studies.
Research will commence by exploring themes relevant to issues around value, data access, sustainability, participant experiences and expectations, and consent, though will be adapted as new issues emerge. We also welcome suggestions from UK Biobank participants about the types of research they would be interested in us conducting.
Publications emanating from our research resource will be published here in due course.
Professor Anneke Lucassen chairs the UK Biobank EAC
Anneke Lucassen is Professor of Genomic Medicine and Director of the Centre for Personalised Medicine at the Wellcome Trust Centre at the University of Oxford (since September 2021). Prior to this she was professor of clinical genetics at the university of Southampton. Her research group clinical ethics, law and society (CELS) , now CELS- Southampton and CELS- Oxford researches the benefits of genomic discovery in practice and its relevance to patients and society using an interdisciplinary approach.
The EAC was established in 2018 and replaced the Ethics and Governance Council (EGC) (for further information about the EGC please see below).
UK Biobank EAC Members
UK Biobank Ethics and Governance Council
The UK Biobank Ethics and Governance Council (EGC) was established by the UK Biobank funders, the Wellcome Trust and the Medical Research Council, when UK Biobank began the recruitment of its 500,000 participants in 2006.
The function of the EGC was to:
- Act as an independent guardian of the UK Biobank Ethics and Governance Framework (EGF) and advise on its revision
- Monitor and report publicly on the conformity of the UK Biobank project with the EGF
- Advise more generally on the interests of research participants and the general public in relation to UK Biobank.
Over the intervening years, the EGC discharged this role and made a considerable contribution to the UK Biobank resource.
It became apparent that during this period UK Biobank had developed at a considerable pace and, as a consequence, the EGC recommended that its oversight role would be more effectively discharged by better integration within UK Biobank as an advisory committee of the UK Biobank Board. This recommendation was accepted by the UK Biobank funders and by the UK Biobank Board and led to the establishment of the EAC.